Studies have demonstrated that breast, prostate, bladder, thyroid, and oral squamous cell carcinomas exhibit de novo synthesis of N-cadherin, while melanoma tends to have a re-expression of N-cadherin that was previously expressed in the melanocyte precursors. Here, CDH2 is linked to melanoma.